Back

Biomarker Identification in Pancreatic Cancer Through Concordant Differential Expression and Interpretable Machine Learning Analyses

2026-02-16 oncology Title + abstract only
View on medRxiv
Show abstract

BackgroundPancreatic ductal adenocarcinoma is one of the most aggressive and lethal malignancies of the gastrointestinal tract. The poor prognosis is largely attributed to late-stage diagnosis, pronounced tumor heterogeneity, and limited therapeutic efficacy. These challenges underscore the urgent need for the identification of robust molecular biomarkers and novel therapeutic targets. MethodsGene expression data from a total of 146 pancreatic tissue samples, comprising 72 normal and 74 tumor s...

Predicted journal destinations